feed,title,long_url,short_url
MedRxiv,Interim Analysis of a Phase I Randomized Clinical Trial on the Safety and Immunogenicity of the mRNA-1283 SARS-CoV-2 Vaccine in Adults,https://medrxiv.org/cgi/content/short/2022.10.18.22281050v1?rss=1,https://bit.ly/3gbcdCI
